Skip to main content
Figure 1 | BMC Pulmonary Medicine

Figure 1

From: Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan

Figure 1

Disposition of patients with pulmonary alveolar proteinosis (PAP) who were enrolled into this study. Participants were stratified according to the presence or absence of granulocyte/macrophage-colony stimulating factor (GM-CSF) autoantibody, and then according to the presence or absence of an underlying disease known to cause PAP.

Back to article page